HLA-DR restrictive supertypes dominate promiscuous T cell recognition: Association of multiple HLA-DR molecules with susceptibility to autoimmune diseases

Journal of Rheumatology

Volumn 24, Issue 2, 1997, Pages 253-261

  Ou, Dawei ^a,b,d   Mitchell, Leslie Ann ^a   Tingle, Aubrey J ^a,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Department of Pediatrics ^*  (Canada)

^c Depts of Pediatrics and Pathology   (India)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

autoimmune diseases; HLA DR antigen; juvenile rheumatoid arthritis; rheumatoid arthritis; T cell

Indexed keywords

HLA DR ANTIGEN;

AUTOIMMUNITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; HLA TYPING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; DISEASE SUSCEPTIBILITY; EPITOPES; HLA-DR ANTIGENS; HUMANS; T-LYMPHOCYTES;

EID: 0031042930     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Winchester R: The molecular basis of susceptibility to rheumatoid arthritis. Adv Immunol 1994;56:389-466.
2. Nepom GT, Ehrlich H: MHC class II molecules and autoimmunity. Ann Rev Immunol 1991;9:493-525.
3. Gregersen PK, Silver J, Winchester RJ: The shared epitope hypothesis: An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30:1205-13.
4. Altmann DM, Sansom D, Marsh SGE: What is the basis for HLA-DQ associations with autoimmune disease? Immunol Today 1991;12:267-70.
5. Ploski R, McDowell TL, Symons JA, et al: Interaction between HLA-DR and HLA-DP and between HLA and interleukin 1α in juvenile rheumatoid arthritis indicates heterogeneity of pathogenic mechanism of the disease. Hum Immunol 1995;42:343-47.
6. Zanelli E, Gonzalez-Gay MA, David CS: Could HLA-DRB1 be the protective locus in rheumatoid arthritis? Immunol Today 1995;16:274-8.
7. Stern LJ, Brown JH, Jardetzky TS, et al: Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994;368:215-21.
8. Fu X-T, Bono CP, Woulfe SL, et al: Pocket 4 of the HLA-DR (α,ß1*0401) molecule is a major determinant of T cell recognition of peptide. J Exp Med 1995;181:915-26.
9. Panina-Bordignon P, Tan A, Termijtelen A, Demotz S, Corradin G, Lanzavecchia A: Universally immunogenic T cell epitopes: Promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur J Immunol 1989;19:2237-42.
10. Olson RR, Reuter JJ, McNicholl J, et al: Acidic residues in the DRß chain third hypervariable region are required for stimulation of a DR(α,ß1*0402)-restricted T cell clone. Hum Immunol 1994;41:193-200.
11. Martinez-Soria E, Steimle V, Burkhardt C, et al: An HLA-DRB α-helix motif shared by DR11 and DR8 alleles is implicated in the pluriallelic restriction of peptide-specific T-cell lines. Hum Immunol 1994;40:279-90.
12. Olson RR, De Magistris MT, Di Tommaso A, Karr RW: Mutations in the third, but not the first or second, hypervariable regions of DR(ß1*0101) eliminate DR1-restricted recognition of a pertussis toxin peptide. J Immunol 1992;148:2703-8.
13. Marshall KW, Liu AF, Canales J, et al: Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands. J Immunol 1994;152:4946-57.
14. Ou D, Mitchell LA, Ho M, et al: Analysis of overlapping T-and B-cell antigenic sites on rubella virus E1 envelope protein: Influence of HLA-DR polymorphism on T-cell clonal recognition. Hum Immunol 1994;39:177-87.
15. Ou D, Mitchell LA, Domeier ME, et al: Characterization of HLA restrictive elements of rubella virus-specific cytotoxic T-cell clone: Influence of HLA-DR4ß chain residue 74 polymorphism on Ag peptide-T cell interaction. Int Immunol 1996;10:1577-86.
16. Marsh SGE, Bodmer JG: HLA class II nucleotide sequences. Hum Immunol 1992;35:1-17.
17. Boehncke W-H, Takeshita T, Pendleton CD, et al: The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition. J Immunol 1993;150:331-41.
18. Zeliszewski D, Gaudebout P, Golvano JJ, et al: Molecular basis for degenerate T-cell recognition of one peptide in the context of several DR molecules. Hum Immunol 1994;41:28-33.
19. Rees ADM, Lombardi G, Scoging A, et al: Functional evidence for the recognition of endogenous peptide by autoreactive T cell clones. Int Immunol 1989;1:624-30.
20. Lombardi G, Sidhu S, Batchelor JR, Lechler RI: Allorecognition of DR1 by T cell from a DR4/DRw13 responder mimics self-restricted recognition of endogenous peptide. Proc Natl Acad Sci USA 1989;86:4190-4.
21. Lamb JR, Rees ADM, Bal V, et al: Prediction and identification of an HLA-DR restricted T cell determinant in the 19 KDa protein of mycobacterium tuberculosis. Eur J Immunol 1988;18:973-6.
22. Ou D, Chong P, McVeish P, Jefferies WA, Gillam S: Characterization of the specificity and genetic restriction of human CD4+ cytotoxic T cell clones reactive to capsid antigen of rubella virus. Virol 1992;191:680-6.
23. Rothbard JB, Busch R, Bal V, Trowsdale J, Lechler RI, Lamb JR: Reversal of HLA restriction by a point mutation in an antigenic peptide. Int Immunol 1989; 1:487-95.
24. Karr RW, Panina-Bordignon P, Yu W-Y, Lanzavecchia A: Antigen-specific T cells with monogamous or promiscuous restriction patterns are sensitive to different HLA-DRß chain substitutions. J Immunol 1991;146:4242-7.
25. Wucherpfennig KW, Sette A, Southwood S, et al: Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. J Exp Med 1994;179:279-90.
26. Ou D, Chong P, Tripet B, Gillam S: Analysis of T-and B-cell epitopes of capsid protein of rubella virus by using synthetic peptides. J Virol 1992;66:1674-81.
27. Malcherek G, Gnau V, Stevanovic S, Rammensee H-G, Lung G, Melms A: Analysis of allele-specific contact sites of natural HLA-DR17 ligands. J Immunol 1994;153:1141-9.
28. Haas JP, Truckenbrodt H, Paul C, Hoza J, Scholz S, Albert ED: Subtypes of HLA-DRB1*03, *08, *11, *12, *13 and *14 in early onset pauciarticular juvenile chronic arthritis with and without iridocyclitis. Clin Exp Rheumatol 1994;(suppl 10)12:S7-S14.
29. Okubo H, Itou K, Tanaka S, Watanabe N, Kashiwagi N, Obata F: Analysis of the HLA-DR gene frequencies in Japanese cases of juvenile rheumatoid arthritis and rheumatoid arthritis by oligonucleotide DNA typing. Rheumatol Int 1993;13:65-9.
30. Nepom BS, Glass DN: Juvenile rheumatoid arthritis and HLA: Report of the Park City III Workshop. J Rheumatol 1992;(suppl 33)19:70-4.
31. Nepom B: The immunogenetics of juvenile rheumatoid arthritis. Rheum Dis Clin North Am 1991;17:825-41.
32. Ploski R, Vinje O, Rønningen KS, et al: HLA class II alleles and heterogeneity of juvenile rheumatoid arthritis. Arthritis Rheum 1993;36:465-72.
33. Grom AA, Giannini EH, Glass DN: Juvenile rheumatoid arthritis and the trimolecular complex (HLA, T cell receptor, and antigen). Arthritis Rheum 1994;37:601-7.
34. Tan PLJ, Farmiloe S, Roberts M, Geursen A, Skinner MA: HLA-DR4 subtypes in New Zealand Polynesians: Predominance of Dw13 in the healthy population and association of Dw15 with rheumatoid arthritis. Arthritis Rheum 1993;36:15-9.
35. Rigby AS, Silman AJ, Voelm L, et al: Investigating the HLA component in rheumatoid arthritis: An additive (dominant) mode of inheritance is rejected, a recessive mode is preferred. Genet Epidemiol 1991;8:153-75.
36. Seglias J, Li EK, Cohen MG, Wong RWS, Potter PK, So AK: Linkage between rheumatoid arthritis susceptibility and the presence of HLA-DR4 and DRß allelic third hypervariable region sequences in southern Chinese persons. Arthritis Rheum 1992;35:163-7.
37. Boki KA, Panayi GS, Vaughan RW, Drosos AA, Moutsopoulos HM, Lanchbury JS: HLA-class II sequence polymorphism and susceptibility to rheumatoid arthritis in Greeks: The HLA-DRß share-epitope hypothesis accounts for the disease in only a minority of Greek patients. Arthritis Rheum 1992;35:749-55.
38. Haas J-P, Nevinny-Stickel C, Schoenwald U, Truckenbrodt H, Suschke J, Albert ED: Susceptible and protective major histocompatibility complex class II alleles in early-onset pauciarticular juvenile chronic arthritis. Hum Immunol 1994;41:225-33.
39. Wan X-L, Kimura A, Dong R-P, Honda K, Tamai H, Sasazuki T: HLA-A and -DRB4 genes in controlling the susceptibility to Hashimoto's thyroiditis. Hum Immunol 1995;42:131-6.
40. Wang FW, Yu ZQ, Xy JJ, Wang XL, Zhang DQ, Chen JL: HLA and hypertrophic Hashimoto's thyroiditis in Shanghai Chinese. Tissue Antigen 1988;32:235-6.
41. Hawkins BR, Lam KSL, Ma JTC, Wang C, Yeung RTT: Strong association between HLA DRw9 and Hashimoto's thyroiditis in southern Chinese. Acta Endocrinologica 1987;114:543-6.
42. Tandon N, Zhang L, Weetman AP: HLA association with Hashimoto's thyroiditis. Clin Endocrinol 1991;34:383-6.
43. Farid NR, Sampson L, Moens H, Barnard JM: The association of goitrous thyroiditis with HLA-DR5. Tissue Antigens 1981;17:265-8.
44. Cowland JB, Andersen V, Halberg P, Morling N: DNA polymorphism of HLA class II genes in systemic lupus erythematosus. Tissue Antigens 1994;43:34-7.
45. Skarsvåg S, Hansen KE, Holst A, Moen T: Distribution of HLA class II alleles among Scandinavian patients with systemic lupus erythematosus (SLE): An increased risk of SLE among non[DRB1*03, DQA1*0501, DQB1*0201] Class II homozygotes? Tissue Antigens 1992;40:128-33.
46. Hashimoto H, Nishimura Y, Dong RP, et al: HLA antigens in Japanese patients with systemic lupus erythematosus. Scand J Rheumatol 1994;23:191-6.
47. Doherty DG, Ireland R, Demaine AG, et al: Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus in southern Chinese. Arthritis Rheum 1992;35:641-6.
48. Barron KS, Silverman ED, Gonzales J, Reveille JD: Clinical, serologic, and immunogenetic studies in childhood-onset systemic lupus erythematosus. Arthritis Rheum 1993;36:348-54.
49. Hartung K, Baur MP, Coldewey R, et al: Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. J Clin Invest 1992;90:1346-51.
50. Yao Z, Kimura A, Hartung K, el al: Polymorphism of the DQA1 promoter region (QAP) and DRB1, QAP, DQA1, DQB1 haplotypes in systemic lupus erythematosus. Immunogenetics 1993;38:421-9.
51. Farid NR, Shi YF, Zou MJ, et al: Hashimoto's thyroiditis is associated with different MHC class II loci. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991, vol 1. Oxford: Oxford University Press, 1991:759-61.
52. Krueger GG, Duvic M: Epidemiology of psoriasis: Clinical issues. J Invest Dermatol 1994;102:15S-8S.
53. Marcusson JA, Möller E: Further studies on psoriasis-associated HLA-Dw/DR7 using PLT cells primed against a familial psoriasis linked HLA haplotype. Tissue Antigens 1986;27:1-9.
54. Haegert DG, Marrosu MG: Genetic susceptibility to multiple sclerosis. Ann Neurol 1994;(suppl 2)36:S204-S10.
55. Kisielow P, Teh HS, Blüthmann H, von Boehmer H: Positive selection of antigen-specific T cells in thymus by restricting MHC molecules. Nature 1988;335:730-3.
56. Fugger L, Michie SA, Rulifson I, Lock CB, McDevitt GS: Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region ß-chain T-cell repertoire and mediates an HLA-DR restricted immune response. Proc Natl Acad Sci USA 1994;91:6151-5.
57. Bill J, Ronchese F, Germain RN, Palmer ED: The contribution of mutant amino acids to alloantigenicity. J Exp Med 1989;170:739-50.
58. bm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor. J Immunol 1991;147:1484-91.
59. Thompson SD, Grom AA, Bailey SS, et al: Patterns of T lymphocyte clonal expansion in HLA-typed patients with juvenile rheumatoid arthritis. J Rheumatol 1995;22:1356-64.
60. Walser-Kuntz DR, Weyand CM, Weaner AJ, O'Fallon WM, Goronzy JJ: Mechanisms underlying the formation of the T cell receptor repertoire in rheumatoid arthritis. Immunity 1995;2:597-605.
61. Penzotti JE, Doherty D, Lybrand TP, Nepom GT: A structural model for TCR recognition of the HLA class II shared epitope sequence implicated in susceptibility to rheumatoid arthritis. J Autoimmun 1996;9:287-93.
62. Hammer J, Gallazzi F, Bono E, et al: Peptide binding specificity of HLA-DR4 molecules: Correlation with rheumatoid arthritis association. J Exp Med 1995;181:1847-55.
63. Massardo L, Jacobelli S, Rodriguez L, Rivero S, Gonzàlez A, Marchetti R: Weak association between HLA-DR4 and rheumatoid arthritis in Chilean patients. Ann Rheum Dis 1990;49:290-2.
64. Singal DP, Green D, Reid B, Gladman DD, Buchanan WW: HLA-D region genes and rheumatoid arthritis (RA): Importance of DR and DQ genes in conferring susceptibility to RA. Ann Rheum Dis 1992;51:23-8.
65. Boey ML, Wee GB, Mohan C, Howe HS, Chan SH, Feng PH: HLA in Singapore Chinese with rheumatoid arthritis. J Rheumatol 1992;19:1517-9.
66. Andersson G, Andersson L, Larhammar D, Rask L, Sigurdardóttir S: Simplifying genetic locus assignment of HLA-DRB genes. Immunol Today 1994;15:58-62.
67. Watanabe Y, Yoshida SH, Ansari AA, Gershwin ME: The contribution of H-2bm12 and non H-2 background genes on murine lupus in NZB. H-2 bm12/b mice. J Autoimmun 1994;7:153-64.
68. Fink CW, Fernandez-Vina M, Stastny P: Clinical and genetic evidence that juvenile arthritis is not a single disease. Paediatric Clin North Am 1995;42:1155-69.
69. Cerna M, Vavrincova P, Havelka S, Ivaskova E, Stastny P: Class II alleles in juvenile arthritis in Czech children. J Rheumatol 1994;21:159-64.
70. Weyand CM, Goronzy JJ: Functional domains on HLA-DR molecules: Implications for the linkage of HLA-DR genes to different autoimmune diseases. Clin Immunol Immunopathol 1994;70:91-8.
71. Weyand CM, Hicok KC, Hunder GG, Goronzy JJ: The HLA-DRB1 locus as a genetic component in giant cell arteritis: Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule. J Clin Invest 1992;90:2355-61.
72. Weyand CM, McCarthy TG, Goronzy JJ: Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest 1995;95:2120-6.
73. Hall PJ, Burman SJ, Laurent MR, et al: Genetic susceptibility to early onset pauciarticular juvenile chronic arthritis: A study of HLA and complement markers in 158 British patients. Ann Rheum Dis 1986;45:464-74.